Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5980-5987

  Li, Zheng ^a   Meng, Zhen Hang ^a   Sayeed, Aejaz ^a   Shalaby, Refaat ^a   Ljung, Britt Marie ^b   Dairkee, Shanaz H ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN P53; RNA; TELOMERASE;

ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; CELL GROWTH; CELL IMMORTALIZATION; CHROMOSOMAL LOCALIZATION; DNA SEQUENCE; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE LOCUS; GENOME; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TUMOR SUPPRESSOR GENE;

ALLELES; BREAST; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; ETHYLNITROSOUREA; GENE DELETION; GENES, P16; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; TELOMERASE; TELOMERE;

EID: 0037108684     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Smith, H. S., Lu, Y., Deng, G., Martinez, O., Krams, S., Ljung, B. M., Thor, A., and Lagios, M. Molecular aspects of early stages of breast cancer progression. J. Cell. Biochem. Suppl., 17G: 144-152, 1993
2. Briand, P., Petersen, O. W., and Van Deurs, B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell. Dev. Biol., 23: 181-188, 1987
3. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res., 50: 6075-6086, 1990
4. Stampfer, M. R., and Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA. 82: 2394-2398, 1985
5. Wang, F., Weaver, V. M., Petersen, O. W., Larabell, C. A., Dedhar, S., Briand, P., Lupu, R., and Bissell, M. J. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA, 95: 14821-14826, 1998
6. Briand, P., and Lykkesfeldt, A. E. An in vitro model of human breast carcinogenesis: Epigenetic aspects. Breast Cancer Res. Treat., 65: 179-187, 2001
7. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., and Miller, F. R. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat., 65: 101-110, 2001
8. Stampfer, M. R., Bodnar, A., Garbe, J., Wong, M., Pan, A., Villeponteau, B., and Yaswen, P. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol. Biol. Cell, 8: 2391-2405, 1997
9. Stampfer, M. R., Garbe, J., Levine, G., Lichtsteiner, S., Vasserot, A. P., and Yaswen, P. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A (-) human mammary epithelial cells. Proc. Natl. Acad. Sci. USA, 98: 4498-4503, 2001
10. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Wash. DC), 274: 2057-2059, 1996
11. Li, Z., Moore, D. H., Meng, Z., Ljung, B-M., Gray, J. W., and Dairkee, S. H. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res., 62: 1000-1003, 2002
12. Stampfer, M. R., and Bartley, J. C. Human mammary epithelial cells in culture: Differentiation and transformation. In: M. E. Lippman and R. B. Dickson (eds.), Breast Cancer: Cellular and Molecular Biology, pp. 1-24. Boston: Kluwer Academic Publishers, 1988
13. Dairkee, S. H., Blayney, C., Smith, H. S., and Hackett, A. J. Monoclonal antibody that defines human myoepithelium. Proc. Natl. Acad. Sci. USA. 82: 7409-7413, 1985
14. Dairkee, S. H., Paulo, E. C., Traquina, P., Moore, D. H., Ljung, B-M., and Smith, H. S. Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells. Cancer Res., 57: 1590-1596, 1997
15. Dairkee, S. H., Deng, G., Stampfer, M. R., Waldman, F. M., and Smith, H. S. Selective cell culture of primary breast carcinoma. Cancer Res., 55: 2516-2519, 1995
16. Vesselinovitch, S. D., Rao, K. V., Mihailovich, N., Rice, J. M., and Lombard, L. S. Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain. Cancer Res., 34: 2530-2538, 1974
17. Dairkee, S. H., and Heid, H. Cytokeratin profile of immunomagnetically separated epithelial subsets of the human mammary gland. In Vitro Cell. Dev. Biol., 29: 427-432, 1993
18. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (Lond.), 396: 84-88, 1998
19. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Bimbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997
20. Osborne, R. J., and Hamshere, M. G. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res., 60: 3706-3712. 2000
21. Shen, C-Y., Yu, J-C., Lo, Y-L., Kuo, C-H., Yue, C-T., Jou, Y-S., Huang, C-S., Lung, J-C., and Wu, C-W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60: 3884-3892, 2000
22. O'Connell, P., Pekkel, V., Fuqua, S. A., Osborne, C. K., Clark, G. M., and Allred, D. C. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J. Natl. Cancer Inst. (Bethesda), 90: 697-703, 1998
23. Villadsen, R., Nielsen, K. V., Bolund, L., and Briand, P. Complete loss of wild-type TP53 in a nontransformed human epithelial cell line is preceded by a phase during which a heterozygous TP53 mutant effectively outgrows the homozygous wild-type cells. Cancer Genet. Cytogenet., 116: 28-34, 2000
24. Musgrove, E. A., Lilischkis, R., Cornish, A. L., Lee, C. S., Setlur, V., Seshadri, R., and Sutherland, R. L. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B, and p21WAF1/CIP1 in human breast cancer. Int. J. Cancer, 63: 584-591, 1995
25. Bisogna, M., Calvano, J. E., Ho, G. H., Orlow, I., Cordon-Cardo, C., Borgen, P. I., and Van Zee, K. J. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Cancer Genet. Cytogenet., 125: 131-138, 2001
26. Milde-Langosch, K., Bamberger, A. M., Rieck, G., Kelp, B., and Loning, T. Over-expression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res. Treat., 67: 61-70, 2001
27. Hayflick, L. Mortality and immortality at the cellular level. A review. Biochemistry, 62: 1180-1190, 1997
28. Mertens, F., Johansson, B., Hoglund, M., and Mitelman, F. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res., 57: 2765-2780, 1997
29. Varrault, A., Ciani, E., Apiou, F., Bilanges, B., Hoffmann, A., Pantaloni, C., Bockaert, J., Spengler, D., and Journot, L. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc. Natl. Acad. Sci. USA, 95: 8835-8840, 1998
30. Abdollahi, A., Roberts, D., Godwin, A. K., Schultz, D. C., Sonoda, G., Testa, J. R., and Hamilton, T. C. Identification of a zinc-finger gene at 6q25: A chromosomal region implicated in development of many solid tumors. Oncogene. 14: 1973-1979, 1997
31. Kas, K., Voz, M. L., Hensen, K., Meyen, E., and Van de Ven, W. J. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J. Biol. Chem., 273: 23026-23032, 1998
32. Abdollahi, A., Godwin, A. K., Miller, P. D., Getts, L. A., Schultz, D. C., Taguchi, T., Testa, J. R., and Hamilton, T. C. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res., 57: 2029-2034, 1997
33. Spengler, D., Villalba, M., Hoffmann, A., Pantaloni, C., Houssami, S., Bockaert, J., and Journot, L. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J., 16: 2814-2825, 1997
34. Bilanges, B., Varrault, A., Basyuk, E., Rodriguez, C., Mazumdar, A., Pantaloni, C., Bockaert, J., Theillet, C., Spengler, D., and Journot, L. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene, 18: 3979-3988, 1999
35. Sandhu, A. K., Hubbard, K., Kaur, G. P., Jha, K. K., Ozer, H. L., and Athwal, R. S. Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc. Natl. Acad. Sci. USA, 91: 5498-5502, 1994
36. Banga, S. S., Kim, S., Hubbard, K., Dasgupta, T., Jha, K. K., Patsalis, P., Hauptschein, R., Gamberi, B., Dalla-Favera, R., Kraemer, P., and Ozer, H. L. SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27. Oncogene, 14: 313-321, 1997
37. Acquati, F., Morelli, C., Cinquetti, R., Bianchi, M. G., Porrini, D., Varesco, L., Gismondi, V., Rocchetti, R., Talevi, S., Possati, L., Magnanini, C., Tibiletti, M. G., Bernasconi, B., Daidone, M. G., Shridhar, V., Smith, D. I., Negrini, M., Barbanti-Brodano, G., and Taramelli, R. Cloning and characterization of a senescence inducing and class 11 tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene, 20: 980-988, 2001
38. Tibiletti, M. G., Sessa, F., Bernasconi, B., Cerutti, R., Broggi, B., Furlan, D., Acquati, F., Bianchi, M., Russo, A., Capella, C., and Taramelli, R. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast. Clin. Cancer Res., 6: 1422-1431, 2000
39. Franco, N., Picard, S. F., Mege, F., Arnould, L., and Lizard-Nacol, S. Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations. Cancer Res., 61: 7955-7958, 2001
40. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. Pten is essential for embryonic development and tumor suppression. Nat. Genet., 19: 348-355, 1998
41. Venkatachalam, S., Shi, Y. P., Jones, S. N., Vogel, H., Bradley, A., Pinkel, D., and Donehower, L. A. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation. EMBO J., 17: 4657-4667, 1998
42. Li, Z., Meng, Z., Chandrasekaran, R., Kuo, W-L., Collins, C. C., Gray, J. W., and Dairkee, S. H. Biallelic inactivation of the thyroid hormone receptor β1 gene in early stage breast cancer. Cancer Res., 62: 1939-1943, 2002
43. KIP2 Expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells. Cancer Res., 59: 5112-5118, 1999